{"ORPHApacket":[{"ORPHApacketID":"251274","date":"2019-12-06 01:10:08","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"251274","Name":[{"lang":"en","label":"Familial hyperaldosteronism type III"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_251274","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Familial hyperaldosteronism"}],"ORPHA":"235936","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_235936"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Familial hyperaldosteronism type III (FH-III) is a rare heritable form of primary aldosteronism (PA) that is characterized by early-onset severe hypertension, non glucocorticoid-remediable hyperaldosteronism, overproduction of 18-oxocortisol and 18-hydroxycortisol, and profound hypokalemia."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"613677","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"3","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adolescent"}]},{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"FH-III"},{"lang":"en","label":"FH3"},{"lang":"en","label":"Familial hyperaldosteronism type 3"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"potassium voltage-gated channel subfamily J member 5"}],"Symbol":"KCNJ5","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"6266"},{"Source":"OMIM","Reference":"600734"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"410296","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) (gain of function) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"17","HPODisorderAssociation":[{"HPOId":"HP:0000822","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000822","HPOTerm":"Hypertension","HPOFrequency":[{"ORPHA":"453310","Name":[{"lang":"en","label":"Obligate (100%)"}]}]},{"HPOId":"HP:0040084","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0040084","HPOTerm":"Abnormal circulating renin","HPOFrequency":[{"ORPHA":"453310","Name":[{"lang":"en","label":"Obligate (100%)"}]}]},{"HPOId":"HP:0002900","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002900","HPOTerm":"Hypokalemia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0008221","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008221","HPOTerm":"Adrenal hyperplasia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0011740","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011740","HPOTerm":"Glucocortocoid-insensitive primary hyperaldosteronism","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000360","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000360","HPOTerm":"Tinnitus","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0000421","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000421","HPOTerm":"Epistaxis","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001324","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001324","HPOTerm":"Muscle weakness","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001657","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001657","HPOTerm":"Prolonged QT interval","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001712","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001712","HPOTerm":"Left ventricular hypertrophy","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001959","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001959","HPOTerm":"Polydipsia","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002018","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002018","HPOTerm":"Nausea","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002150","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002150","HPOTerm":"Hypercalciuria","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002170","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002170","HPOTerm":"Intracranial hemorrhage","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0002315","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002315","HPOTerm":"Headache","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0200114","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0200114","HPOTerm":"Metabolic alkalosis","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0011739","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011739","HPOTerm":"Dexamethasone-suppresible primary hyperaldosteronism","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}